IO Biotech Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 78

Employees

  • Latest Deal Type
  • Liquidation

IO Biotech General Information

Description

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IO Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Liquidation 01-Apr-2026 Completed Bankruptcy: Liquidation
9. Merger/Acquisition 21-Jan-2026 Cancelled Generating Revenue
8. Debt - General 23-Dec-2024 Completed Generating Revenue
7. PIPE 11-Aug-2023 Completed Generating Revenue
6. IPO 05-Nov-2021 Completed Generating Revenue
5. Later Stage VC (Series C) 07-Oct-2021 Completed Generating Revenue
4. Later Stage VC (Series B) 13-Jan-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 22-Jul-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Jan-2016 $11.9M $12.5M Completed Startup
1. Early Stage VC (Series B) 22-Jan-2015 $595K $595K Completed Startup
To view IO Biotech’s complete valuation and funding history, request access »

IO Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares 164,758 $63.03 $63.03 1x $63.03 8.99%
Ordinary Shares 53,303 $57.48 $57.48 1x $57.48 2.91%
To view IO Biotech’s complete cap table history, request access »

IO Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based o
Drug Discovery
Copenhagen, Denmark
78 As of 2025

San Diego, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IO Biotech Competitors (50)

One of IO Biotech’s 50 competitors is ImmunityBio, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImmunityBio Formerly VC-backed San Diego, CA
Aura Biosciences Formerly VC-backed Boston, MA
Hansa Biopharma Corporation Lund, Sweden
GT Biopharma Corporation San Francisco, CA
Alaunos Therapeutics Formerly VC-backed Fort Lauderdale, FL
You’re viewing 5 of 50 competitors. Get the full list »

IO Biotech Patents

IO Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023374733-A1 Tgf-beta-1 vaccine Pending 04-Nov-2022
EP-4611788-A1 Tgf-beta-1 vaccine Pending 04-Nov-2022
US-20260176313-A1 Tgf-beta-1 vaccine Pending 04-Nov-2022
WO-2024094850-A1 Tgf-beta-1 vaccine Inactive 04-Nov-2022
GB-202216449-D0 Tgf-beta1 vaccine Inactive 04-Nov-2022 C07K14/495
To view IO Biotech’s complete patent history, request access »

IO Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IO Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view IO Biotech’s complete esg history, request access »

IO Biotech FAQs

  • When was IO Biotech founded?

    IO Biotech was founded in 2014.

  • Where is IO Biotech headquartered?

    IO Biotech is headquartered in Copenhagen, Denmark.

  • What is the size of IO Biotech?

    IO Biotech has 78 total employees.

  • What industry is IO Biotech in?

    IO Biotech’s primary industry is Drug Discovery.

  • Is IO Biotech a private or public company?

    IO Biotech is a Private company.

  • What is IO Biotech’s current revenue?

    The current revenue for IO Biotech is .

  • How much funding has IO Biotech raised over time?

    IO Biotech has raised $435M.

  • Who are IO Biotech’s competitors?

    ImmunityBio, Aura Biosciences, Hansa Biopharma, GT Biopharma, and Alaunos Therapeutics are some of the 50 competitors of IO Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process